Business Segments · Other segment items

Reportable Segment — Other segment items

Insmed Reportable Segment — Other segment items increased by 27.1% to $210.49M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 75.9%, from $119.70M to $210.49M. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Other segment items shows an upward trend with a 34.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryOther
SignalLower is better
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026

How to read this metric

High volatility or large values may indicate significant non-recurring operational adjustments.

Detailed definition

This captures miscellaneous operational expenses or income items specific to the reportable segment that do not fall int...

Peer comparison

Varies widely by company based on internal segment accounting policies.

Metric ID: insm_segment_reportable_segment_other_segment_items

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$57.93M$57.93M$57.93M$57.93M$73.80M$73.80M$73.80M$73.80M$76.79M$90.38M$94.72M$113.06M$119.70M$127.65M$150.93M$165.65M$210.49M
QoQ Change+0.0%+0.0%+0.0%+27.4%+0.0%+0.0%+0.0%+4.0%+17.7%+4.8%+19.4%+5.9%+6.6%+18.2%+9.8%+27.1%
YoY Change+27.4%+27.4%+27.4%+27.4%+4.0%+22.5%+28.3%+53.2%+55.9%+41.2%+59.3%+46.5%+75.9%
Range$57.93M$210.49M
CAGR+38.1%
Avg YoY Growth+38.2%
Median YoY Growth+28.3%
Current Streak16+ quarters growth

Frequently Asked Questions

What is Insmed's reportable segment — other segment items?
Insmed (INSM) reported reportable segment — other segment items of $210.49M in Q1 2026.
How has Insmed's reportable segment — other segment items changed year-over-year?
Insmed's reportable segment — other segment items increased by 75.9% year-over-year, from $119.70M to $210.49M.
What is the long-term trend for Insmed's reportable segment — other segment items?
Over 3 years (2022 to 2025), Insmed's reportable segment — other segment items has grown at a 34.5% compound annual growth rate (CAGR), from $231.71M to $563.93M.
What does reportable segment — other segment items mean?
Residual operational costs or income specific to the business segment.